2159 |
COAGULATION FACTOR X |
F10 |
FX |
FXA |
613872 |
3528 |
ENSG00000126218 |
OTTHUMG00000017374 |
P00742 |
FA10_HUMAN |
Activated factor Xa heavy chain |
Factor X light chain |
Factor X heavy chain |
Stuart factor |
Stuart-Prower factor |
COAGULATION FACTOR XA |
COAGULATION FACTOR X PRECURSOR (EC 3.4.21.6) (STUART FACTOR) (STUART- PROWER FACTOR). [SOURCE:UNIPROT/SWISSPROT;ACC:P00742] |
T84631 |
Uniprot Status | Swiss-Prot |
Interpro Short Name | Peptidase_S1_S6 |
Human Readable Name | DRUGGABLE GENOME |
Uniprot Evidence | 1: Evidence at protein level |
Human Readable Name | PROTEASE |
Interpro Name | Peptidase S1/S6, chymotrypsin/Hap |
Interpro Type | Domain |
Interpro Acc | IPR001254 |
Target Class | Enzymes |
Target Subclass | EC:3.4.21.6 |
Target Main Class | Enzymes |
Target Subclass | 3.4.21.6 |
Gene Biotype | PROTEIN_CODING |
PROTEASE |
DRUGGABLE GENOME |
inhibitor (inhibitory) |
Trial Name | betrixaban, PRT054021, Factor Xa inhibitor |
Novel drug target | Established target |
Mechanism of Interaction | Coagulation factor X inhibitor |
inhibitor (inhibitory) |
Novel drug target | Established target |
Trial Name | otamixaban, XRP0673 |
antagonist (inhibitory) |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Coagulation factor X inhibitor |
Trial Name | rivaroxaban, BAY 59-7939,Xarelto |
inhibitor (inhibitory) |
Trial Name | TAK-442 |
Novel drug target | Established target |
Mechanism of Interaction | Coagulation factor X inhibitor |
n/a |
Trial Name | LY-517717 |
Novel drug target | Established target |
inhibitor (inhibitory) |
Mechanism of Interaction | Coagulation factor X inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Trial Name | edoxaban, DU-176b |
Novel drug target | Established target |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Coagulation factor X inhibitor |
Trial Name | Apixaban |
n/a |
Trial Name | idraparinux, SanOrg 34006 |
Novel drug target | Established target |
inhibitor (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Coagulation factor X inhibitor |
n/a |
Trial Name | tinzaparin sodium injection,Innohep |
Novel drug target | Established target |
n/a |
Trial Name | ProFibrix B.V/ |
Novel drug target | Established target |
F10 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
F10 | Display Id |
COAGULATION FACTOR X PRECURSOR (EC 3.4.21.6) (STUART FACTOR) (STUART- PROWER FACTOR). [SOURCE:UNIPROT/SWISSPROT;ACC:P00742] | Description |
ENSG00000126218 | Ensembl Gene Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
ENSG00000126218 | Ensembl Gene Id |
2159 | Entrez Gene Id |
F10 | Gene Symbol |
Target Main Class | Enzymes |
Target Subclass | 3.4.21.6 |
F10 | Gene Symbol |
Target Class | Enzymes |
Target Subclass | EC:3.4.21.6 |
ENSG00000126218 | Ensembl Gene Id |
P00742 | Uniprot Accession |
FA10_HUMAN | Uniprot Id |
Uniprot Status | Swiss-Prot |
Interpro Short Name | Peptidase_S1_S6 |
Human Readable Name | DRUGGABLE GENOME |
PROTEASE, DRUGGABLE GENOME |
F10 | GENE_SYMBOL |
Coagulation factor X | UNIPROT |
Factor X light chain | UNIPROT |
ENSG00000126218 | Gene Symbol |
F10 | Ensembl Id |
DRUGGABLE GENOME |
2159 | Gene ID |
FX | dGene Synonym |
FXA | dGene Synonym |
PROTEASE |
F10 | TTD Gene Abbreviation |
T84631 | TTD Target ID |